Stock listing
NASDAQ:CVKD Cadrenal Therapeutics, Inc. Stock
Home listing (NASDAQ) of Cadrenal Therapeutics, Inc.
Follow Cadrenal Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CVKD
$1.06 USD -0.07 (-6.2%)
Close on Nov 4, 2026
- Day range
- $1.05 – $1.15 USDNov 4, 2026
- Volume
- 43,133 sharesNov 4, 2026
- Market cap
- $3.78M USDAt the close on Nov 4, 2026 · price × 3.57M shares outstanding
- 52-week range
- $0.816 – $13.11 USDLowest and highest trades, Nov 5, 2025 – Nov 5, 2026
- Traded on an average day
- $726,970 USDMedian day 61,690 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CVKD · Home | $1.06 USD | -0.07 (-6.2%) | 43,133 | $1.10 | $1.15 | $1.05 | $1.13 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:CVKD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.06 | -0.07 | -6.2% | $1.10 | $1.15 | $1.05 | 43,133 | |
| $1.13 | +0.09 | +8.7% | $1.05 | $1.14 | $1.05 | 55,293 | |
| $1.04 | +0.055 | +5.6% | $0.923 | $1.23 | $0.923 | 284,786 | |
| $0.985 | +0.042 | +4.4% | $0.94 | $1.00 | $0.94 | 80,670 | |
| $0.943 | -0.004 | -0.5% | $1.00 | $1.00 | $0.94 | 44,027 | |
| $0.948 | +0.006 | +0.6% | $0.946 | $0.981 | $0.912 | 37,452 | |
| $0.942 | +0.032 | +3.5% | $0.90 | $0.99 | $0.86 | 60,380 | |
| $0.91 | -0.05 | -5.2% | $0.96 | $0.96 | $0.91 | 52,210 | |
| $0.96 | -0.01 | -1.0% | $0.965 | $1.00 | $0.93 | 38,200 | |
| $0.97 | -0.05 | -4.9% | $1.03 | $1.07 | $0.96 | 19,800 | |
| $1.02 | -0.02 | -1.9% | $1.02 | $1.03 | $1.00 | 28,200 | |
| $1.04 | -0.02 | -1.9% | $1.04 | $1.10 | $1.00 | 48,700 | |
| $1.06 | -0.03 | -2.8% | $1.06 | $1.10 | $0.998 | 152,200 | |
| $1.09 | +0.12 | +12.4% | $0.96 | $1.12 | $0.96 | 173,200 | |
| $0.97 | -0.05 | -4.9% | $0.99 | $1.03 | $0.965 | 104,200 | |
| $1.02 | +0.023 | +2.3% | $0.93 | $1.10 | $0.92 | 344,300 | |
| $0.997 | +0.125 | +14.3% | $0.889 | $1.06 | $0.874 | 376,400 | |
| $0.872 | -0.038 | -4.2% | $0.918 | $0.918 | $0.816 | 111,400 | |
| $0.91 | -0.02 | -2.2% | $0.974 | $0.974 | $0.90 | 82,400 | |
| $0.93 | -0.042 | -4.3% | $0.994 | $0.994 | $0.87 | 311,200 | |
| $0.972 | -0.018 | -1.8% | $1.01 | $1.07 | $0.917 | 1,781,700 | |
| $0.99 | +0.044 | +4.7% | $0.943 | $1.05 | $0.90 | 98,000 | |
| $0.946 | +0.006 | +0.6% | $0.97 | $1.00 | $0.935 | 63,000 | |
| $0.94 | -0.03 | -3.1% | $0.98 | $1.005 | $0.85 | 149,600 | |
| $0.97 | -0.11 | -10.2% | $1.09 | $1.09 | $0.97 | 109,200 | |
| $1.08 | -0.01 | -0.9% | $1.10 | $1.10 | $1.05 | 21,700 | |
| $1.09 | -0.03 | -2.7% | $1.10 | $1.13 | $1.08 | 38,200 | |
| $1.12 | -0.03 | -2.6% | $1.16 | $1.16 | $1.07 | 75,600 | |
| $1.15 | -0.05 | -4.2% | $1.25 | $1.25 | $1.13 | 224,700 | |
| $1.20 | -0.12 | -9.1% | $1.31 | $1.355 | $1.19 | 119,000 | |
| $1.32 | +0.20 | +17.9% | $1.12 | $1.348 | $1.06 | 269,000 | |
| $1.12 | +0.03 | +2.8% | $1.11 | $1.139 | $1.06 | 73,500 | |
| $1.09 | +0.02 | +1.9% | $1.07 | $1.11 | $1.06 | 66,800 | |
| $1.07 | -0.05 | -4.5% | $1.12 | $1.16 | $1.07 | 113,600 | |
| $1.12 | +0.04 | +3.7% | $1.10 | $1.14 | $1.08 | 44,900 | |
| $1.08 | +0.03 | +2.9% | $1.05 | $1.10 | $1.01 | 55,600 | |
| $1.05 | -0.01 | -0.9% | $1.06 | $1.12 | $1.04 | 56,400 | |
| $1.06 | -0.03 | -2.8% | $1.07 | $1.10 | $1.054 | 47,600 | |
| $1.09 | -0.09 | -7.6% | $1.17 | $1.189 | $1.00 | 228,600 | |
| $1.18 | -0.01 | -0.8% | $1.17 | $1.20 | $1.14 | 119,800 | |
| $1.19 | -0.01 | -0.8% | $1.22 | $1.23 | $1.14 | 114,600 | |
| $1.20 | -0.02 | -1.6% | $1.20 | $1.26 | $1.16 | 161,800 | |
| $1.22 | -0.06 | -4.7% | $1.26 | $1.295 | $1.20 | 177,400 | |
| $1.28 | -0.05 | -3.8% | $1.34 | $1.41 | $1.27 | 168,600 | |
| $1.33 | -0.18 | -11.9% | $1.40 | $1.53 | $1.28 | 388,300 | |
| $1.51 | -0.24 | -13.7% | $1.49 | $1.58 | $1.42 | 783,800 | |
| $1.75 | +0.21 | +13.6% | $1.64 | $2.29 | $1.46 | 21,599,200 | |
| $1.54 | -0.025 | -1.6% | $1.56 | $1.60 | $1.50 | 31,100 | |
| $1.565 | +0.015 | +1.0% | $1.52 | $1.622 | $1.52 | 48,200 | |
| $1.55 | +0.02 | +1.3% | $1.56 | $1.643 | $1.49 | 24,700 | |
| $1.53 | -0.04 | -2.5% | $1.56 | $1.61 | $1.50 | 39,200 | |
| $1.57 | -0.04 | -2.5% | $1.69 | $1.69 | $1.54 | 36,200 | |
| $1.61 | +0.02 | +1.3% | $1.62 | $1.62 | $1.541 | 36,200 | |
| $1.59 | -0.05 | -3.0% | $1.65 | $1.725 | $1.58 | 60,000 | |
| $1.64 | -0.07 | -4.1% | $1.75 | $1.775 | $1.62 | 81,000 | |
| $1.71 | -0.05 | -2.8% | $1.76 | $1.82 | $1.64 | 59,400 | |
| $1.76 | -0.11 | -5.9% | $1.88 | $1.88 | $1.71 | 37,200 | |
| $1.87 | +0.01 | +0.5% | $1.88 | $1.914 | $1.79 | 27,900 | |
| $1.86 | +0.02 | +1.1% | $1.85 | $1.969 | $1.76 | 35,900 | |
| $1.84 | -0.10 | -5.2% | $1.945 | $1.98 | $1.77 | 63,600 | |
| $1.94 | 0.00 | 0.0% | $1.975 | $2.12 | $1.92 | 46,300 | |
| $1.94 | -0.01 | -0.5% | $1.96 | $2.013 | $1.91 | 20,000 | |
| $1.95 | +0.08 | +4.3% | $1.90 | $2.05 | $1.87 | 30,100 | |
| $1.87 | -0.09 | -4.6% | $1.98 | $1.991 | $1.87 | 25,700 | |
| $1.96 | -0.07 | -3.4% | $2.07 | $2.10 | $1.90 | 33,000 | |
| $2.03 | +0.07 | +3.6% | $1.96 | $2.17 | $1.96 | 40,700 |
- Ticker
- NASDAQ:CVKD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 7, 2026
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics
Oct 7, 2026
Closed $0.972 (-1.8%) on Oct 7, 2026
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
Sep 21, 2026
Closed $1.12 (+2.8%) on Sep 22, 2026
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Sep 3, 2026
Closed $1.28 (-3.8%) on Sep 3, 2026
Cadrenal Therapeutics Announces Positive Outcome from FDA Type D Meeting for Phase 3 Registration Study of CAD-1005 in Heparin-Induced Thrombocytopenia
Aug 31, 2026
Closed $1.75 (+13.6%) on Aug 31, 2026
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Aug 13, 2026
Closed $1.87 (+0.5%) on Aug 14, 2026
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Jul 21, 2026
Closed $2.17 (+3.8%) on Jul 21, 2026
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
Jul 13, 2026
Closed $2.42 (-16.3%) on Jul 13, 2026
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun 30, 2026
Closed $3.17 (-5.1%) on Jul 1, 2026
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
Jun 24, 2026
Closed $2.98 (-2.6%) on Jun 24, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · September 2026
Investor Presentation (May 2026)
Investor deck · 18 slides · May 2026
Investor Presentation (December 2025)
Investor deck · 23 slides · Dec 11, 2025
Investor Presentation (September 2025)
Investor deck · 26 slides · Sep 15, 2025
Cadrenal Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 27 in the last 12 months · 92 in all · newest Oct 7, 2026 · oldest 2023
- Decks
- 14 decks · latest September 2026
Where Cadrenal Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CVKD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CVKD | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Cadrenal Therapeutics, Inc.